SecBot SecBot
SECBOTREPLAY Home › Report › TELA

TELA · North Run 13G/A 7.8% stake

TELA Bio, Inc. · SC 13G/A filed Nov 13, 2026 at 16:00 ET

At the news

NEUTRALIMPACT 2/10

SC 13G/A filed Nov 13, 2026 at 16:00 ET

North Run Capital, LP filed an amended Schedule 13G disclosing beneficial ownership of 3,528,296 shares of TELA Bio common stock, representing 7.8% of shares outstanding as of September 30, 2026. This is an amendment to a prior filing; no prior stake data for North Run is available in the provided documents to determine direction of change. The filing is a routine passive stake update with no material new information.

  • North Run Capital, LP and related entities beneficially own 3,528,296 shares of TELA Bio common stock.
  • Stake represents 7.8% of outstanding shares as of September 30, 2026.
  • Shares held by North Run - Due North Partners, LP, a pooled investment vehicle managed by North Run Capital.
  • Filing certifies passive intent under Rule 13d-1(c); securities not held to change or influence control.

Replay the market's reaction

Step through every 5 minutes around the news, then see how it compares with similar events.

Subscribe for Full Access